Skip to main content

Articles

Page 1 of 19

  1. HIV early infant diagnosis (HEID) at the centralized laboratory faces many challenges that impact the cascade of timely HEID. Point of Care (PoC) HEID has shown to reduce test turnaround times, allow for task ...

    Authors: Siriel Boniface, Anange Lwilla, Hellen Mahiga, Doreen Pamba, Otto Geisenberger, John France, Rebecca Mokeha, Lilian Njovu, Abisai Kisinda, Nyanda Elias Ntinginya, Michael Hoelscher, Arne Kroidl and Issa Sabi
    Citation: AIDS Research and Therapy 2024 21:33
  2. Intestinal parasitic infections (IP) are a major source of morbidity in people living with Human immunodeficiency virus (HIV), particularly in resource-limited settings, mostly as a result of high viral load. ...

    Authors: Mengistu Endalamaw, Abel Alemneh, Gashaw Azanaw Amare, Abebe Fenta and Habtamu Belew
    Citation: AIDS Research and Therapy 2024 21:32
  3. Uganda Ministry of Health (MOH) recommends a first HIV DNA-PCR test at 4–6 weeks for early infant diagnosis (EID) of HIV-exposed infants (HEI) and immediate return of results. WHO recommends initiating antiret...

    Authors: Stella M. Migamba, Tamara Nsubuga Nyombi, Edirisa Juniour Nsubuga, Andrew Kwiringira, Augustina Delaney, Steven Ndugwa Kabwama, Mary Nakafeero, Benon Kwesiga, Daniel Kadobera, Phoebe Monalisa-Mayambala, Lilian Bulage, Alex Riolexus Ario and Julie R. Harris
    Citation: AIDS Research and Therapy 2024 21:31
  4. The COVID-19 pandemic has put the provision of health services globally at risk. In Sub-Saharan Africa, it had a major impact on HIV services. However, there is a lack of data on the post-pandemic period. This...

    Authors: Roberto Benoni, Francesco Cavallin, Virginia Casigliani, Annachiara Zin, Dara Giannini, Izilda Chaguruca, Vasco Cinturao, Fernando Chinene, Giulia Brigadoi, Daniele Donà, Giovanni Putoto and Carlo Giaquinto
    Citation: AIDS Research and Therapy 2024 21:29
  5. Self-management is the most important strategy to improve quality of life in patients with a chronic disease. Despite the increasing number of people living with HIV (PLWH) in low-income countries, very little...

    Authors: Tegene Legese Dadi, Yadessa Tegene, Nienke Vollebregt, Girmay Medhin and Mark Spigt
    Citation: AIDS Research and Therapy 2024 21:28
  6. Human genetic contribution to HIV progression remains inadequately explained. The type 1 interferon (IFN) pathway is important for host control of HIV and variation in type 1 IFN genes may contribute to diseas...

    Authors: Sara Bohnstedt Mørup, Preston Leung, Cavan Reilly, Brad T. Sherman, Weizhong Chang, Maja Milojevic, Ana Milinkovic, Angelike Liappis, Line Borgwardt, Kathy Petoumenos, Roger Paredes, Shweta S. Mistry, Cameron R. MacPherson, Jens Lundgren, Marie Helleberg, Joanne Reekie…
    Citation: AIDS Research and Therapy 2024 21:27
  7. Authors: Munyaradzi Mapingure, Innocent Chingombe, Tafadzwa Dzinamarira, Brian Moyo, Chesterfield Samba, Delight Murigo, Owen Mugurungi, Elliot Mbunge, Rutendo Birri Makota, Grant Murewanhema and Godfrey Musuka
    Citation: AIDS Research and Therapy 2024 21:26

    The original article was published in AIDS Research and Therapy 2024 21:18

  8. Bacillus Calmette-Guérin (BCG) reactions are the most common cause of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive infants who initiate antiretroviral therapy (ART). There is limited evid...

    Authors: Percina Machava, Winete Joaquim, Joseph Borrell, Shannon Richardson, Uneisse Cassia, Muhammad Sidat, Alice Maieca, Cláudia Massitela, Yara Quelhas, Cafrina Mucuila, Beatriz Elias, Massada da Rocha, H. Simon Schaaf and W. Chris Buck
    Citation: AIDS Research and Therapy 2024 21:25
  9. Erythema multiforme (EM) is an immune-mediated mucocutaneous condition characterized by hypersensitivity reactions to antigenic stimuli from infectious agents and certain drugs. The most commonly implicated in...

    Authors: Shumani Charlotte Manenzhe, Razia Abdool Gafaar Khammissa, Sindisiwe Londiwe Shangase and Mia Michaela Beetge
    Citation: AIDS Research and Therapy 2024 21:24
  10. Dolutegravir (DTG)-based antiretroviral therapy (ART) is currently the preferred first-line treatment for persons living with HIV (PLHIV) including children and adolescents in many low- and middle-income count...

    Authors: Irene Nakatudde, Elizabeth Katana, Eva Laker Agnes Odongpiny, Esther Alice Nalugga, Barbara Castelnuovo, Mary Glenn Fowler and Philippa Musoke
    Citation: AIDS Research and Therapy 2024 21:23
  11. Initiation of ART among people living with HIV (PLWH) having a CD4 count ≤ 350cells/µl, produces poor immunological recovery, putting them at a high risk of opportunistic infections. To mitigate this, PLWH on ...

    Authors: Silvano S. Twinomujuni, Esther C Atukunda, Jackson K. Mukonzo, Musinguzi Nicholas, Felicitas Roelofsen and Patrick E. Ogwang
    Citation: AIDS Research and Therapy 2024 21:22
  12. Maintaining people living with HIV (PLWHIV) in clinical care is a global priority. In the Metro Detroit area of Michigan, approximately 30% of PLWHIV are out of care. To re-engage lost-to-follow-up patients, W...

    Authors: L. V. Bonadonna, E. Guerrero, T. McClendon, S. Union, D. Kabbani, D. Wittmann, J. Cohn and J. Veltman
    Citation: AIDS Research and Therapy 2024 21:21
  13. HIV testing remains an important tool in identifying people living with HIV/AIDS (PLWHA). An early diagnosis of HIV can lead to a prolonged life expectancy if treatment is initiated promptly. Indicator conditi...

    Authors: Lina Martina Würfel, Anja Potthoff, Sandeep Nambiar and Adriane Skaletz-Rorowski
    Citation: AIDS Research and Therapy 2024 21:20
  14. Syphilis is an infection caused by the bacteria Treponema pallidum. It is mainly transmitted through oral, vaginal and anal sex, in pregnancy and through blood transfusion. Syphilis develops in primary, secondary...

    Authors: Sukoluhle Khumalo, Yves Mafulu, Victor Williams, Normusa Musarapasi, Samson Haumba and Nkululeko Dube
    Citation: AIDS Research and Therapy 2024 21:19
  15. We conducted secondary data analysis using a biobehavioral survey dataset of 1538 MSM from Zimbabwe. Survey participants were screened for the four symptoms suggestive of tuberculosis infection using the WHO T...

    Authors: Munyaradzi Mapingure, Innocent Chingombe, Tafadzwa Dzinamarira, Brian Moyo, Chesterfield Samba, Delight Murigo, Owen Mugurungi, Elliot Mbunge, Rutendo Birri Makota, Grant Murewanhema and Godfrey Musuka
    Citation: AIDS Research and Therapy 2024 21:18

    The Correction to this article has been published in AIDS Research and Therapy 2024 21:26

  16. As the population of people with HIV ages, concerns over managing age-related comorbidities, polypharmacy, immune recovery, and drug-drug interactions while maintaining viral suppression have arisen. We presen...

    Authors: Sharon Walmsley, Don E. Smith, Miguel Górgolas, Pedro E. Cahn, Thomas Lutz, Karine Lacombe, Princy N. Kumar, Brian Wynne, Richard Grove, Gilda Bontempo, Riya Moodley, Chinyere Okoli, Michelle Kisare, Bryn Jones, Andrew Clark and Mounir Ait-Khaled
    Citation: AIDS Research and Therapy 2024 21:17
  17. Young female sex workers (YFSWs) face a higher risk of HIV infection compared to older workers, but there is a lack of comprehensive data on their sexual practices and HIV infection risks, which may present un...

    Authors: Olivier Mukuku, Yannick Nkiambi Kiakuvue, Georges Yumba Numbi, Bienvenu Mukuku Ruhindiza, Christian Kakisingi, Claude Mulumba Mwamba and Joe Kabongo Katabwa
    Citation: AIDS Research and Therapy 2024 21:16
  18. Antiretroviral Therapy (ART) is pivotal in extending the lives of people living with HIV (PLWH) and minimizing transmission. Rapid ART initiation, defined as commencing ART within seven days of HIV diagnosis, ...

    Authors: Cheng Chen, Hao Chen, Lingli Wu, Qin Gong and Jingchun He
    Citation: AIDS Research and Therapy 2024 21:15
  19. HIV partner disclosure rates remain low among pregnant women living with HIV in many African countries despite potential benefits for women and their families. Partner disclosure can trigger negative responses...

    Authors: Adelline Twimukye, Yussif Alhassan, Beate Ringwald, Thokozile Malaba, Landon Myer, Catriona Waitt, Mohammed Lamorde, Helen Reynolds, Saye Khoo and Miriam Taegtmeyer
    Citation: AIDS Research and Therapy 2024 21:14
  20. Cardiovascular disease (CVD) remains a leading cause of death in people living with HIV. Myocardial fibrosis is well-described in HIV infection acquired in adulthood. We evaluate the burden of fibrosis by card...

    Authors: Jason L. Williams, Frances Hung, Elizabeth Jenista, Piers Barker, Hrishikesh Chakraborty, Raymond Kim, Andrew W. McCrary, Svati H. Shah, Nathan Thielman and Gerald S. Bloomfield
    Citation: AIDS Research and Therapy 2024 21:13
  21. Increased incidence of lifestyle diseases as side-effects of antiretroviral therapy (ART) have been reported in people living with HIV (PLWH). Few studies have evaluated obesity and hidden obesity in Japanese ...

    Authors: K. Konishi, H. Nakagawa, T. Asaoka, Y. Kasamatsu, T. Goto and M. Shirano
    Citation: AIDS Research and Therapy 2024 21:12
  22. Maternal transmission of human immunodeficiency virus (HIV) commonly occurs from mother to child during pregnancy, delivery, and breastfeeding which accounts for almost all the new HIV infections among childre...

    Authors: Agani Afaya and Aloysia Ispriantari
    Citation: AIDS Research and Therapy 2024 21:11
  23. Acquired Immune Deficiency Syndrome (AIDS) is a highly dangerous infectious disease caused by the Human Immunodeficiency Virus (HIV), a virus that attacks the human immune system. To explore the correlation be...

    Authors: Pengfei Meng, Guichun Zhang, Xiuxia Ma, Xue Ding, Xiyuan Song, Shuyuan Dang, Ruihan Yang and Liran Xu
    Citation: AIDS Research and Therapy 2024 21:10
  24. The Integrated Bio-Behavioural Surveillance Survey of 2022–2023 among key populations report from Zanzibar has been released. The prevalence of HIV is estimated to be 21.1%, 11.4%, and 9.3% among Female Sex Wo...

    Authors: Mansour Maulid Mshenga and Weiming Tang
    Citation: AIDS Research and Therapy 2024 21:9
  25. Studies on antiretroviral therapy (ART) in children living with HIV (CLHIV) are limited due to the small population and low accession rate of ART.

    Authors: Ting Zeng, Xin Chen, Xiao-Yi Zhang, Chao-Xian Lian, Rong-Rong Yang, Li-Ling Yu, Xiao-Kang Liao, Dan-Dan Huang, Yu-Ning Zhang and Hong-Min Cao
    Citation: AIDS Research and Therapy 2024 21:8
  26. Availability of anti-retroviral treatment has changed HIV in to a manageable chronic disease, making effective self-management essential. However, only a few studies in low- and middle-income countries (LMICs)...

    Authors: Tegene Legese Dadi, Anja M. C. Wiemers, Yadessa Tegene, Girmay Medhin and Mark Spigt
    Citation: AIDS Research and Therapy 2024 21:7
  27. Antiretroviral therapy client satisfaction is a significant tool that enables to strengthen the quality of life of the clients. The study aimed to assess the satisfaction of clients with antiretroviral therapy...

    Authors: Bayisa Abdissa, Rahel Abdissa, Jiregna Derega and Senahara Korsa Wake
    Citation: AIDS Research and Therapy 2024 21:6
  28. Human Immunodeficiency Virus (HIV) infection remains a public health concern in many countries. The increased life expectancy in the post-Antiretroviral Therapy (ART) era has led to an increased risk of cardiovas...

    Authors: Mawulorm K. I. Denu, Ritika Revoori, Maame Araba E. Buadu, Oluwakemi Oladele and Kofi Poku Berko
    Citation: AIDS Research and Therapy 2024 21:5
  29. There is limited data on dolutegravir (DTG)-associated weight gain from settings with a dual burden of HIV and overnutrition.

    Authors: Didier M. Mukuna, Tom Decroo and Clara M. Nyapokoto
    Citation: AIDS Research and Therapy 2024 21:4
  30. Malakoplakia is a rare chronic granulomatous disease characterized by the presence of Michaelis-Gutmann bodies (MGBs) within histiocytic aggregates. It predominantly affects immunocompromised individuals, incl...

    Authors: Mohammed Alsaeed, Mohamed Mursi, Nazik Eltayeb, Hadi Kuriry, Salafa Albaghli and Yasir Alrusayni
    Citation: AIDS Research and Therapy 2024 21:3
  31. Empyema caused by Streptococcus constellatus (S. constellatus) is rare in patients with HIV. To analyze the clinical data of a patient living with HIV (PLHIV), who got empyema caused by S. constellatus, invest...

    Authors: Hong-Hong Yang, Mei Li, Qing Yu, Qian Liu and Min Liu
    Citation: AIDS Research and Therapy 2024 21:2
  32. We assessed whether the impact of cabotegravir plus rilpivirine on inflammation reduction differs from that of oral antiretrovirals, using real-world data. Inflammatory biomarkers and lipid profiles were follo...

    Authors: Eisuke Adachi, Makoto Saito, Amato Otani, Michiko Koga and Hiroshi Yotsuyanagi
    Citation: AIDS Research and Therapy 2024 21:1
  33. Low-adherence to Anti-retroviral therapy (ART) negatively affects the clinical, immunological, and virologic outcomes of patients. Adherence is the most important factor in determining Antiretroviral Therapy (...

    Authors: Yihenew Zurbachew, Desta Hiko, Girma Bacha and Hailu Merga
    Citation: AIDS Research and Therapy 2023 20:91
  34. Intensive adherence counseling (IAC) is the global standard of care for people living with human immunodeficiency virus (PLHIV) who have unsuppressed VL after ≥ 6 months of first-line anti-retroviral therapy (...

    Authors: Jonathan Izudi, Barbara Castelnuovo, Rachel King and Adithya Cattamanchi
    Citation: AIDS Research and Therapy 2023 20:90
  35. Major depression is the most common neuropsychiatric disorder among people living with HIV (PLWH) and is predictive of high morbidity and mortality among them. This study estimated the prevalence and explored ...

    Authors: Waheed Adeola Adedeji, Qing Ma, Abiodun Muhammed Raji, Raymond Cha, Olaniran Mudasiru Rasaki, Alan Hutson, Babafemi O. Taiwo, Man E. Charurat, Oyindamola B. Yusuf, Fatai Adewale Fehintola, Oye Gureje and Gene D. Morse
    Citation: AIDS Research and Therapy 2023 20:89
  36. In spite of the global decreasing mortality associated with HIV, adolescents living with HIV (ADLHIV) in sub-Saharan Africa still experience about 50% mortality rate. We sought to evaluate survival rates and d...

    Authors: Nicholas Tendongfor, Joseph Fokam, Collins Ambe Chenwi, Fabrice Léo Tamhouo Nwabo, Armanda Nangmo, Njume Debimeh, Suzie Tetang Ndiang Moyo, Marie Patrice Halle, Anne-Esther Njom-Nlend, Paul Koki Ndombo and Alexis Ndjolo
    Citation: AIDS Research and Therapy 2023 20:88
  37. Surging HIV prevalence across countries of Central and Eastern Europe (CEE) is largely a result of poor HIV care engagement and a lack of comprehensive support for key populations. This is fostered by widespre...

    Authors: Ana-Maria Schweitzer, Arian Dišković, Veronica Krongauz, Julie Newman, Janez Tomažič and Nina Yancheva
    Citation: AIDS Research and Therapy 2023 20:87
  38. In 2016, the Canada-International HIV and Rehabilitation Research Collaborative established a framework of research priorities in HIV, aging and rehabilitation. Our aim was to review and identify any new emerg...

    Authors: Kelly K. O’Brien, Francisco Ibáñez-Carrasco, Kelly Birtwell, Graeme Donald, Darren A. Brown, Andrew D. Eaton, Bakita Kasadha, Emma Stanmore, Natalie St. Clair-Sullivan, Liam Townsend, Jaime H. Vera and Patricia Solomon
    Citation: AIDS Research and Therapy 2023 20:86
  39. This case series of 5 patients with severely necrotic mpox highlights the predominantly necrotic nature of lesions seen in cases of severe mpox as shown by skin and lung biopsy, as well as the extensive dissem...

    Authors: Sandra Rajme-López, Ever A. Corral-Herrera, Andrea C. Tello-Mercado, Karen M. Tepo-Ponce, Raúl E. Pérez-Meléndez, Ángela Rosales-Sotomayor, Grecia Figueroa-Ramos, Karla López-López, Judith G. Domínguez-Cherit, Oswaldo San-Martín-Morante, Marcela Saeb-Lima, Armando Gamboa-Domínguez, Alfredo Ponce-de-León, Brenda Crabtree-Ramírez, Pilar Ramos-Cervantes and Guillermo M. Ruíz-Palacios
    Citation: AIDS Research and Therapy 2023 20:85
  40. Globally, over 40 million lives have been claimed by HIV/AIDS. In Ghana, more than 350,000 people are living with HIV. Non-disclosure of HIV status is a major barrier to HIV/AIDS eradication; yet, little is kn...

    Authors: Robert Kaba Alhassan, Jerry John Nutor, Akua Gyamerah, Emily Boakye-Yiadom, Emmanuel Kasu, Evelyn Acquah and Emmanuel Doe
    Citation: AIDS Research and Therapy 2023 20:84
  41. The World Health Organization (WHO) recommends an evidence-based package of care to reduce mortality and morbidity among people with advanced HIV disease (AHD). Adoption of these recommendations by national gu...

    Authors: Thomas C. Scheier, Nabila Youssouf, Mosepele Mosepele, Cecilia Kanyama, Olukemi Adekanmbi, Sulaiman Lakoh, Conrad K. Muzoora, Graeme Meintjes, Dominik Mertz, John W. Eikelboom and Sean Wasserman
    Citation: AIDS Research and Therapy 2023 20:83
  42. Human immunodeficiency virus (HIV) infection is associated with an elevated incidence of cervical cancer, and accelerated disease progression, but the underlying mechanisms are not well understood. This study ...

    Authors: Peizhi Wang, Baojun Yang, Huang Huang, Peiyi Liang, Bin Long, Lin Chen, Lijie Yang, Lianhua Tang, Liping Huang and Huichao Liang
    Citation: AIDS Research and Therapy 2023 20:82
  43. Gay, bisexual, and other men who have sex with men (GBMSM) experience a high prevalence of psychosocial health problems, such as harmful substance use and depression, as well as being disproportionately affect...

    Authors: Rosalie Hayes, Will Nutland, Michael Rayment, Sonali Wayal, Vanesa Apea, Amanda Clarke, Alan McOwan, Ann Sullivan, Monica Desai, Andrew Jajja, Brian Rice, Rob Horne, Sheena McCormack and Mitzy Gafos
    Citation: AIDS Research and Therapy 2023 20:81
  44. The Russian Federation’s invasion in Ukraine has resulted social hardship, millions of internally displaced persons, the destruction of medical infrastructure, and limited access to HIV services. There is no a...

    Authors: Olena Karagodina, Oksana Kovtun, Myroslava Filippovych and Oleksandr Neduzhko
    Citation: AIDS Research and Therapy 2023 20:80
  45. People with human immunodeficiency virus have an increased risk of developing AIDS-defining malignancies including Burkitt lymphoma. Survival outcomes in HIV-associated Burkitt lymphoma remain worse than non-H...

    Authors: Ashley M. Tuin, Clare M. Wieland, Elizabeth J. Dort, Danielle B. Dilsaver and Manasa Velagapudi
    Citation: AIDS Research and Therapy 2023 20:79
  46. Psychological discomfort and sleep problems are considered separate disorders. Due to the high prevalence of both disorders among people living with HIV (PLWH), this study was designed to evaluate how those ch...

    Authors: Mohammad Ebrahimzadeh Mousavi, Safieh Mohammad Nejad, Maryam Shafaati, Rosa Mykyta-Chomsky, Samaneh Akbarpour and Fatemeh Hadavandsiri
    Citation: AIDS Research and Therapy 2023 20:78
  47. Pre-exposure prophylaxis is the use of antiretroviral medications by HIV-negative individuals to prevent infection before exposure. Ethiopia has made progress in reducing new HIV infections, but the burden rem...

    Authors: Belayneh Fentahun Shibesh, Aragaw Bitew Admas, Amarech Wondie Lake, Samuel Befekadu Getu and Daniel Tarekegn Worede
    Citation: AIDS Research and Therapy 2023 20:77
  48. With effective antiretroviral therapy (ART), many persons living with HIV (PLHIV) live to old age. Caring for aged PLHIV necessitates the engagement of caregivers and patients to establish agreed-upon goals of...

    Authors: Scovia Nalugo Mbalinda, Derrick Amooti Lusota, Martin Muddu, David Musoke and Mathew Nyashanu
    Citation: AIDS Research and Therapy 2023 20:76
  49. HIV seroprevalence in Nigeria is increasing among men who have sex with men (MSM) from 14% to 2007 to 23% in 2014, threatening progress towards ending the epidemic in the country. Expanding access to HIV testi...

    Authors: Lisa R. Hirschhorn, Adedotun Adetunji, Aima A. Ahonkhai, Bibilola Oladeji, Olutosin A. Awolude, Lisa M. Kuhns, Jude Onumabor, Kehinde M. Kuti, Olayinka Omigbodun, Amy K. Johnson, Ogochukwu Okonkwor, Babafemi Taiwo and Robert Garofalo
    Citation: AIDS Research and Therapy 2023 20:75